Table 2.
Antimicrobial susceptibility testing against ESBL-producing Escherichia coli, Klebsiella species, Acinetobacter species and others.
| Antibiotics |
Escherichia coli n = 174 |
Klebsiella Species n = 74 |
Acinetobacter Species n = 18 |
Others n = 6 |
Total n = 272 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | |
| TZP | 45 | 1 | 128 | 43 | 1 | 30 | 17 | 0 | 1 | 2 | 0 | 4 | 107 | 2 | 163 |
| (25.9) | (0.6) | (73.6) | (58.1) | (1.4) | (40.5) | (94.4) | (0.0) | (5.6) | (33.3) | (0.0) | (66.7) | (39.3) | (0.7) | 3 (59.9) | |
| MEM | 33 | 1 | 140 | 46 | 0 | 28 | 17 | 0 | 1 | 2 | 0 | 4 | 98 | 1 | 173 |
| (19.0) | (0.6) | (80.5) | (62.2) | (0.0) | (37.8) | (94.4) | (0.0) | (5.6) | (33.3) | (0.0) | (66.7) | (36.0) | (0.4) | (63.6) | |
| IPM | 35 | 2 | 137 | 44 | 0 | 30 | 17 | 0 | 1 | 2 | 0 | 4 | 98 | 2 | 172 |
| (20.1) | (1.1) | (78.7) | (59.5) | (0.0) | (40.5) | (94.4) | (0.0) | (5.6) | (33.3) | (0.0) | (66.7) | (36.0) | (0.7) | 63.2) | |
| G | 63 | 1 | 110 | 45 | 0 | 29 | 15 | 0 | 3 | 3 | 0 | 3 | 126 | 1 | 145 |
| (36.2) | (0.6) | (63.2) | (60.8) | (0.0) | (39.2) | (83.3) | (0.0) | (16.7) | (50.0) | (0.0) | (50.0) | (46.3) | (0.4) | (53.3) | |
| AK | 19 | 5 | 150 | 31 | 3 | 40 | 15 | 0 | 3 | 2 | 0 | 4 | 67 | 8 | 197 |
| (10.9) | (2.9) | (86.2) | (41.9) | (4.1) | (54.1) | (83.3) | (0.0) | (16.7) | (33.3) | (0.0) | (66.7) | (24.6) | (2.9) | (72.4) | |
| NA | 156 | 3 | 15 | 64 | 0 | 10 | 17 | 0 | 1 | 5 | 0 | 1 | 242 | 3 | 27 |
| (89.7) | (1.7) | (8.6) | (86.5) | (0.0) | (13.5) | (94.4) | (0.0) | (5.6) | (83.3) | (0.0) | (16.7) | (89.0) | (1.1) | (9.9) | |
| NOR | 150 | 0 | 24 | 58 | 1 | 15 | 17 | 0 | 1 | 6 | 0 | 0 | 231 | 1 | 40 |
| (86.2) | (0.0) | (13.8) | (78.4) | (1.4) | (20.3) | (94.4) | (0.0) | (5.6) | (100.0) | (0.0) | (0.0) | (84.9) | (0.4) | (14.7) | |
| CIP | 141 | 0 | 33 | 61 | 0 | 13 | 17 | 0 | 1 | 5 | 0 | 1 | 234 | 0 | 48 |
| (81.0) | (0.0) | (19.0) | (82.4) | (0.0) | (17.6) | (94.4) | (0.0) | (5.6) | (83.3) | (0.0) | (16.7) | (82.4) | (0.0) | (17.6) | |
| SXT | 146 | 0 | 28 | 64 | 0 | 10 | 17 | 0 | 1 | 4 | 0 | 2 | 231 | 0 | 41 |
| (83.9) | (0.0) | (16.1) | (86.5) | (0.0) | (13.5) | (94.4) | (0.0) | (5.6) | (66.7) | (0.0) | (33.3) | (84.9) | (0.0) | (15.1) | |
| F | 30 | 3 | 141 | 45 | 2 | 27 | 15 | 0 | 3 | 3 | 0 | 3 | 93 | 5 | 174 |
| (17.2) | (1.7) | (81.0) | (60.8) | (2.7) | (36.5) | (83.3) | (0.0) | (16.7) | (50.0) | (0.0) | (50.0) | (34.2) | (1.8) | (64.0) | |
| SCF | 50 | 2 | 122 | 45 | 1 | 28 | 16 | 1 | 1 | 2 | 0 | 4 | 113 | 4 | 155 |
| (28.7) | (1.1) | (70.1) | (60.8) | (1.4) | (37.8) | (88.9) | (5.6) | (5.6) | (33.3) | (0.0) | (66.7) | (41.5) | (1.5) | (57.0) | |
| FOS | 8 | 0 | 166 | 28 | 4 | 42 | 15 | 1 | 2 | 3 | 0 | 3 | 54 | 5 | 213 |
| (4.6) | (0.0) | (95.4) | (37.8) | (5.40 | (56.8) | (83.3) | (5.6) | (11.1) | (50.0) | (0.0) | (50.0) | (19.9) | (1.8) | (78.3) | |
R = resistant, I = intermediate, S = susceptible, NA = nalidixic acid, SXT = co-trimoxazole, CIP = ciprofloxacin, CN = gentamicin, SCF = sulbactam/cefoperazone, TZP = piperacillin/tazobactam, MEM = meropenem, IPM = imipenem, F = nitrofurantoin, AK = amikacin, FOS = fosfomycin.